Modern approaches to the treatment of irritable bowel syndrome through the prism of the “intestine — brain” axis

Ye.S. Sirchak


Irritable bowel syndrome is one of the most common functional disorders of the gastrointestinal tract. Significant role in its occurrence is played by the interaction between the factors of the environment and the individual characteristics of the patient. Among the latter, there are disorders of intestinal motility, visceral hypersensitivity, decreased activity of the immune system, violation of the intestinal barrier function, low-grade inflammation and changes in intestinal microbiota due to disorders in the functioning of signaling system between the intestines and the brain. The article presents modern information on the influence of intestinal microbiota on the brain functioning through the axis, which includes the central nervous system, the vagus nerve, the exchange of tryptophan, neuroendocrine and neuroimmune systems, the hypothalamic-pituitary-adrenal, autonomic nervous and enteric nervous system. The expediency and effectiveness of using Alflorex (В.infantis 35624 strain) to promote the reduction of all clinical symptoms of the irritable bowel syndrome due to its immunomodulatory, anti-inflammatory effects, as well as the effect on the exchange of tryptophan and sero­tonin, which, in turn, modulates motor activity and visceral hypersensitivity through the normalization of signaling between the intestines and the brain.


irritable bowel syndrome; “intestine — brain” axis; intestinal microbiota; В.infantis 35624


Tereshchenko E. Innovative approaches to microbiome correction in pediatric practice. Zdorov`ja Ukrai'ny (Pedyatryja). 2016;(37):4-6. (in Russian).

Evrense А, Ceylan ME. The Gut-Brain Axis: The Missing Link in Depression. Clin Psychopharmacol Neurosci. 2015 Dec 31;13(3):239-44. doi: 10.9758/cpn.2015.13.3.239.

Mohajeri MH, La Fata G, Steinert RE, Weber P. Relationship between the gut microbiome and brain function. Nutr Rev. 2018 Jul 1;76(7):481-496. doi: 10.1093/nutrit/nuy009.

Rodrigues-Amorim D, Rivera-Baltanás T, Regueiro B, et al. The role of the gut microbiota in schizophrenia: Current and future perspectives. World J Biol Psychiatry. 2018 Feb 21:1-15. doi: 10.1080/15622975.2018.1433878.

Zhan G, Yang N, Li S, et al. Abnormal gut microbiota composition contributes to cognitive dysfunction in SAMP8 mice. Aging (Albany NY). 2018 Jun 10;10(6):1257-1267. doi: 10.18632/aging.101464.

Abhari K, Hosseini H. Psychobiotics: Next Generation Treatment for Mental Disorders. J Clin Nutr Diet. 2018;4:1. doi: 10.4172/2472-1921.100063.

Moreno-Navarrete JM, Serino M, Blasco-Baque V et al. Gut Microbiota Interacts with Markers of Adipose Tissue Browning, Insulin Action and Plasma Acetate in Morbid Obesity. Mol Nutr Food Res. 2018 Feb;62(3). doi: 10.1002/mnfr.201700721.

Morris G, Berk M, Carvalho A, et al. The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease. Mol Neurobiol. 2017 Aug;54(6):4432-4451. doi: 10.1007/s12035-016-0004-2.

Lozupone M, Seripa D, Stella E et al. Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry. Expert Rev Proteomics. 2017 Sep;14(9):809-824. doi: 10.1080/14789450.2017.1375857.

Кozlov AYe, Kazancev AV, Vjazovchenko VA, Sizov SV, Abrosimova YuS. The relationship between the microbiota of GIT and mental health of a person. Bûlleten’ medicinskih internet-konferencij. 2015;5(12):1692. (in Russian).

Fernandez-Real JМ, Serino M, Blasco G, et al. Gut microbiota interacts with brain microstructure and function. J Clin Endocrinol Metab. 2015 Dec;100(12):4505-13. doi: 10.1210/jc.2015-3076.

Bienenstock J, Kunze W, Forsythe P. Microbiota and the gut–brain axis. Nutr Rev. 2015 Aug;73 Suppl 1:28-31. doi: 10.1093/nutrit/nuv019.

Foster JA, Rinaman L, Cryan JF. Stress and the gut-brain axis: Regulation by the microbiome. Neurobiol Stress. 2017 Mar 19;7:124-136. doi: 10.1016/j.ynstr.2017.03.001.

Sampson TR, Mazmanian SK. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe. 2015 May 13;17(5):565-76. doi: 10.1016/j.chom.2015.04.011.

Bilbo SD, Schwarz JM. The immune system and developmental programming of brain and behavior. Front Neuroendocrinol. 2012 Aug;33(3):267-86. doi: 10.1016/j.yfrne.2012.08.006.

Kelly J, Daly K, Moran AW Ryan S, Bravo D, Shirazi-Beechey SP. Composition and diversity of mucosa-associated microbiota along the entire length of the pig gastrointestinal tract; dietary influences. Environ Microbiol. 2017 Apr;19(4):1425-1438. doi: 10.1111/1462-2920.13619.

Mangiola F, Ianiro G, Franceschi F, Fagiuoli S, Gasbarrini G, Gasbarrini A. Gut microbiota in autism and mood disorders. World J Gastroenterol. 2016 Jan 7;22(1):361-8. doi: 10.3748/wjg.v22.i1.361.

Liang S, Wu X, Hu X, Wang T, Feng J. Recognizing Depression from the Microbiota–Gut–Brain Axis. Int J Mol Sci. 2018 May 29;19(6). pii: E1592. doi: 10.3390/ijms19061592.

Bienenstock J, Kunze WA, Forsythe P. Disruptive physiology: olfaction and the microbiome-gut-brain axis. Biol Rev Camb Philos Soc. 2018 Feb;93(1):390-403. doi: 10.1111/brv.12348.

Lamas B, Richard ML, Sokol H. Caspase recruitment domain 9, microbiota, and tryptophan metabolism: dangerous liaisons in inflammatory bowel diseases. Curr Opin Clin Nutr Metab Care. 2017 Jul;20(4):243-247. doi: 10.1097/MCO.0000000000000382.

Clark A, Mach N. Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes. J Int Soc Sports Nutr. 2016 Nov 24;13:43. doi: 10.1186/s12970-016-0155-6.

Malinova TS, Dijkstra CD, de Vries HE. Serotonin: A mediator of the gut-brain axis in multiple sclerosis. Mult Scler. 2018 Aug;24(9):1144-1150. doi: 10.1177/1352458517739975.

Morris G, Berk M, Carvalho A, et al. The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease. Mol Neurobiol. 2017 Aug;54(6):4432-4451. doi: 10.1007/s12035-016-0004-2.

Mohajeri MH, Brummer RJM,· Rastall RA, et al. The role of the microbiome for human health: from basic science to clinical applications. Eur J Nutr. 2018 May 10. doi: 10.1007/s00394-018-1703-4.

Hashimoto M, Maekawa M, Katakura M, Hamazaki K, Matsuoka Y. Possibility of polyunsaturated fatty acids for the prevention and treatment of neuropsychiatric illnesses. J Pharmacol Sci. 2014;124(3):294-300.

Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015 Apr-Jun;28(2):203-209.

Singh RB, Fedacko J, Pella D, et al. The gut-brain-axis and the heart. MOJ Public Health. 2018;7(3):129-138. doi: 10.15406/mojph.2018.07.00218.

Sinagra E, Morreale GC, Mohammadian G, et al. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World J Gastroenterol. 2017 Sep 28;23(36):6593-6627. doi: 10.3748/wjg.v23.i36.6593.

Raskov H, Burcharth J, Pommergaard H-C, Rosenberg J. Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes. 2016 Sep 2;7(5):365-83. doi: 10.1080/19490976.2016.1218585.

Schwille-Kiuntke J, Enck P, Zendler C, et al. Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil. 2011 Nov;23(11):e479-88. doi: 10.1111/j.1365-2982.2011.01779.x.

Sundin J, Rangel I, Repsilber D, Brummer RJ. Cytokine Response after Stimulation with Key Commensal Bacteria Differ in Post-Infectious Irritable Bowel Syndrome (PI-IBS) Patients Compared to Healthy Controls. PLoS One. 2015 Sep 14;10(9):e0134836. doi: 10.1371/journal.pone.0134836.

Jeffery IB, O’Toole PW, Öhman L, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 2012 Jul;61(7):997-1006. doi: 10.1136/gutjnl-2011-301501.

Sundin J, Rangel І, Kumawat AK, Hultgren-Hörnquist E, Brummer RJ. Aberrant mucosal lymphocyte number and subsets in the colon of post-infectious irritable bowel syndrome patients. Scand J Gastroenterol. 2014 Sep;49(9):1068-75. doi: 10.3109/00365521.2014.926982.

Oleskin AV, Shenderov BA. Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota. Microb Ecol Health Dis. 2016 Jul 5;27:30971. doi: 10.3402/mehd.v27.30971.

Harper А, Naghibi MM, Garcha D. The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome. Foods. 2018 Jan 26;7(2). pii: E13. doi: 10.3390/foods7020013.

Bischoff SC, Barbara G, Buurman W, et al. Intestinal permeability-a new target for disease prevention and therapy. BMC Gastroenterol. 2014 Nov 18;14:189. doi: 10.1186/s12876-014-0189-7.

Stepanov YuM, Budzak YaI. Role of visceral hypersensitivity in the development of irritable bowel syndrome. Gastroenterologia. 2018;52(2):104-108. doi: 10.22141/2308-2097.52.2.2018.132617. (in Russian).

Bubnova EA, Fomenko OYu, Khalif IL, Pavlenko VV. Patterns of colonic dismotility and visceral hypersensitivity at various clinical variants of irritable bowel syndrome. Rossijskij zurnal gastroenterologii, gepatologii, koloproktologii. 2016;26(6):32-39. (in Russian).

Luczynski P, Tramullas M, Viola M, et al. Microbiota regulates visceral pain in the mouse. Elife. 2017 Jun 20;6. pii: e25887. doi: 10.7554/eLife.25887.

Anitha M, Vijay-Kumar M, Sitaraman SV, Gewirtz AT, Srinivasan S. Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling. Gastroenterology. 2012 Oct;143(4):1006-16.e4. doi: 10.1053/j.gastro.2012.06.034.

Brint EK, MacSharry J, Fanning A, Shanahan F, Quigley EM. Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am J Gastroenterol. 2011 Feb;106(2):329-36. doi: 10.1038/ajg.2010.438.

Brenne DM, Chey WD. Bifidobacterium infantis 35624: A Novel Probiotic for the Treatment of Irritable Bowel Syndrome. Rev Gastroenterol Disord. 2009 Winter;9(1):7-15.

Park C, Caroline Р, Brietzke E, et al. Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism? Brain. Behavior. and Immunity. 2018. Jul 18. pii: S0889-1591(18)30304-0. doi: 10.1016/j.bbi.2018.07.006.

Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010 Nov 10;170(4):1179-88. doi: 10.1016/j.neuroscience.2010.08.005.

O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005 Mar;128(3):541-51.

Kim N, Yun M, Oh YJ, Choi HJ. Mind-altering with the gut: Modulation of the gut-brain axis with Probiotics. J Microbiol. 2018 Mar;56(3):172-182. doi: 10.1007/s12275-018-8032-4.

Allen AP, Clarke G, Cryan JF, Eamonn MM, Dinan Q, Dinan TG. Bifidobacterium infantis 35624 and other probiotics in the management of irritable bowel syndrome. Strain specificity, symptoms, and mechanisms. Curr Med Res Opin. 2017 Jul;33(7):1349-1351. doi: 10.1080/03007995.2017.1322571.

Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015 Apr 9;161(2):264-76. doi: 10.1016/j.cell.2015.02.047.

Parkes GC, Sanderson JD, Whelan K. Treating irritable bowel syndrome with probiotics: the evidenceTreating irritable bowel syndrome with probiotics: the evidence. Proc Nutr Soc. 2010 May;69(2):187-94. doi: 10.1017/S002966511000011X.

Korpela R, Niittynen L. Probiotics and irritable bowel syndrome. Microb Ecol Health Dis. 2012 Jun 18;23. doi: 10.3402/mehd.v23i0.18573.

Quigley E, Catanzaro D, Wycherley C, Tillisch K.  Tolerability and safety of the probiotic Bifidobacterium infantis 35624:  review of clinical and postmarketing data. In: Abstracts of ACG 2010, American College of Gastroenterology Annual Scientific Meeting. October 15-20, 2010. San Antonio, Texas, USA, Abstract 1305. Am J Gastroenterol. 2010;105(Suppl 1):S480-S481.  

Stepanov YuM. Alflorex – Bifidobacterium infantis 35624 already in Ukraine. Gastroenterologia. 2017;51(3):11. (in Russian).

Copyright (c) 2018 GASTROENTEROLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2018


   Seo анализ сайта